<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">107614</id>
  <title nil="true"/>
  <common-name>4-(2-Amino-4-methyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-yl)phenyl]-2,5-dihydropyrimidin-2-imine</common-name>
  <description>4-(2-Amino-4-methyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-yl)phenyl]-2,5-dihydropyrimidin-2-imine belongs to the morpholines, a subclass of oxazinanes within the organic compounds. This organoheterocyclic compound has the chemical formula C18H20N6OS and an average molecular weight of 368.46 g/mol. In terms of biological activity, two protein targets have been recorded for this compound: Cyclin-dependent kinase 2 (CDK2) and Cyclin-A2 (CCNA2).</description>
  <cas>1059105-22-4</cas>
  <pubchem-id nil="true"/>
  <chemical-formula>C18H20N6OS</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-05T13:59:48Z</created-at>
  <updated-at type="dateTime">2026-05-14T18:55:33Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB08219</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C(SC(N)=N1)C1=N\C(=N/C2=CC=C(C=C2)N2CCOCC2)N=CC1</moldb-smiles>
  <moldb-formula>C18H20N6OS</moldb-formula>
  <moldb-inchi>InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-5,7H,6,8-11H2,1H3,(H2,19,21)/b22-18-</moldb-inchi>
  <moldb-inchikey>RPSZSAKYXPWBRR-PYCFMQQDSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">368.456</moldb-average-mass>
  <moldb-mono-mass type="decimal">368.1419303</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.02</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM103507</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00073339</susdat-id>
  <iupac>4-methyl-5-[(2Z)-2-{[4-(morpholin-4-yl)phenyl]imino}-2,5-dihydropyrimidin-4-yl]-1,3-thiazol-2-amine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Oxazinanes</klass>
  <subklass>Morpholines</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0116004</sync-id>
  <structure-inchikey>RPSZSAKYXPWBRR-PYCFMQQDSA-N</structure-inchikey>
  <structure-fingerprint>8000000000000000020000000002000000044000000000000000000000000000000000020000001000000000000000000000000000010000100800000000000000100000000008000100100000002040000000000000000000000000000020000020000010000000381100200000000010000020000000000400000000000000000000000000010000000000000000000000080000002040000020000000000000820000400200000400040000080000000000000000000000000000000000000000000000000000000000020000002000000000000000000400000030000400000000010000000000004000000000000000c0000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle>ï¾­Þ������������������������€���`������@(������@(������@(������@(�������h�������@(�������(�������(�������(�������(������@(������@h�������@h�������@(������@h�������@h��������(�������`�������`������� ������`�������`�������(�������h��������`�����������h���h���h��� ��h��� ��(��	$�	
*�����
�$���h��h��h���h���h��� ���������������	� ��(������h������h����B������������	���������������������������</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:42:27Z</structure-indexed-at>
</compound>
